ShanXi C&Y Pharmaceutical Group Co.,LTD. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 189.49 million compared to CNY 183.19 million a year ago. Net income was CNY 18.28 million compared to net loss of CNY 2.16 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0757 compared to basic loss per share from continuing operations of CNY 0.0089 a year ago. Diluted earnings per share from continuing operations was CNY 0.0757 compared to diluted loss per share from continuing operations of CNY 0.0089 a year ago.